Sign in

MLEC on Nasdaq

Moolec Science SA

Moolec Science SA is a food and Kindred Products company in the Cayman Islands.1 Its shares trade on Nasdaq under the symbol MLEC.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$5.6MRevenue, fiscal 20242
-$7.3MNet income, fiscal 20242

Compare with BranchOut Food Inc., Sow Good Inc. or Chanson International Holding, or pick any stock.

  • TickerMLEC on Nasdaq1
  • IndustryFood and Kindred Products1
  • HeadquartersE91
  • Incorporated inCayman Islands3
  • Business address89 Nexus Way, Camana Bay, Grand Cayman, Ky1-90093
  • Filer categoryNon-accelerated filer, Emerging growth company3

See how the biggest companies compare on our leaderboards

Bay, Grand Cayman KY1-9009. Our principal website address is www.moolecscience.com and our Investor Relations website address is ir.moolecscience.com.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-160.8%Operating margin2
-130.0%Net margin2
521.5%Revenue growth, 20242
-107.3%Return on equity2
-$9.5MFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Crop Protection brought in 54% of the revenue Moolec Science SA broke down this way in fiscal 2025.

  1. Crop Protection$181.9M554%down 19% from 2024
  2. Crop Nutrition$89.5M527%down 38% from 2024
  3. Seed And Integrated Products$63.7M519%down 34% from 2024
  4. Emerging Solutions$270.7K50%down 84% from 2024
Business segments by year
Business segments202320242025
Crop Protection$205.8M$223.5M$181.9M
Crop Nutrition$157.3M$144.8M$89.5M
Seed And Integrated Products$56.9M$96.4M$63.7M
Emerging Solutions$1.5M$1.7M$270.7K

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue64¢$5.2M
  • Research and development22¢$1.8M
  • Interest1¢$41.1K
  • Income tax13¢$1.0M

Out of $5.6M in revenue.2 The company lost money this year.

Financial statements

Revenue2$5.6M in 2024+522% since 2023
0$2.0M$4.0M$6.0M2023: $905.0K$905.0K20232024: $5.6M$5.6M2024+522%
Operating income2-$9.0M in 2024+148% since 2022
-$10.0M-$7.5M-$5.0M-$2.5M02022: -$3.7M-$3.7M20222023: -$6.7M-$6.7M2023+82%2024: -$9.0M-$9.0M2024+36%
Net income2-$7.3M in 2024+62% since 2022
-$60.0M-$40.0M-$20.0M02022: -$4.5M-$4.5M20222023: -$51.8M-$51.8M2023+1044%2024: -$7.3M-$7.3M2024−86%

Every line of the income statement as filed: the last 3 fiscal years, latest first.5

Period ending2025-06-302024-06-302023-06-30
Revenues from contracts with customers$333.6M$466.4M$420.9M
Government grants$3.4K$197.5K$93.5K
Initial recognition and changes in the fair value of biological assets at the point of harvest$1.8M-$45.7K$610.6K
Cost of sales-$203.4M-$279.4M-$235.5M
Changes in the net realizable value of agricultural products after harvest-$1.5M-$2.4M-$4.4M
Research and development expenses-$15.1M-$17.4M-$15.9M
Selling, general and administrative expenses-$125.9M-$126.3M-$116.5M
Share of profit or loss of joint ventures and associates-$36.9M-$21.0M$47.7M
Other income or expenses, net-$56.6M-$703.3K$1.1M
Operating (loss) profit-$104.2M$19.3M$98.0M
Financial cost-$41.8M-$37.6M-$33.6M
Other financial results-$24.0M-$9.6M-$13.7M
(Loss) Profit before income tax-$170.0M-$28.0M$50.8M
Income tax-$6.6M-$1.1M$2.3M
Items that may be subsequently reclassified to profit and loss-$3.7M-$1.1M-$911.9K
Equity holders of the parent-$114.0M-$32.9M$39.1M
Foreign exchange differences on translation of foreign operations from joint ventures-$802.2K$977.5K-$46.5K
Non-controlling interests-$66.3M$2.7M$11.7M
Foreign exchange differences on translation of foreign operations-$2.9M-$2.1M-$865.4K
Total comprehensive (loss)-$180.3M-$30.2M$50.7M
Items that will not be subsequently reclassified to loss and profit-$1.5M
Revaluation of property, plant and equipment, net of tax, of joint ventures and associates-$184.6K
Revaluation of property, plant and equipment, net of tax-$1.3M
Equity holders of the parent-$111.5M-$32.7M$40.4M
Non-controlling interests-$65.2M$3.6M$12.7M
(Loss) Profit for the year-$176.6M-$29.1M$53.1M
Basic (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)-$17.25-$5.61$8.80
Diluted (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)-$17.25-$5.61$8.80

Compare Moolec Science SA with another company

Corporate structure

Moolec Science SA sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Moolec Science SA

  • Moolec Science SA E9

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Moolec Science SA reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$1.1M6 Jun 30, 2023$8.9K6 Jun 30, 2022+12706.5%
Operating-lease assets (leased space)$443.2K2 Jun 30, 2024$43.8K2 Jun 30, 2023+911.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$5.4M2 Jun 30, 2024$2.5M2 Jun 30, 2023+113.2%
Long-term investments$99.0K6 Jun 30, 2023

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$262.5K2 Jun 30, 2024$251.4K2 Jun 30, 2023+4.4%
Intangible assets, net (excluding goodwill)$9.0M2 Jun 30, 2024$8.5M2 Jun 30, 2023+5.4%

Inventory

ItemLatestA year beforeChange
Inventory, total$6.3M2 Jun 30, 2024$465.7K2 Jun 30, 2023+1248.3%

Leadership

Who has led Moolec Science SA, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Raibar Alejandro Carlos Antalich2026–now

Chief financial officer

  1. Valeria Ines Falottico2026–now
Board members and other officers (6)

Timeline

  1. Mar 18, 2026New chief executive Raibar Alejandro Carlos Antalich becomes CEO7

Filings

175 filings to the SEC since October 2021: 5 annual reports, 9 insider forms, 7 large holders, 154 other. The latest 20:

  1. Oct 7, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Sep 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  3. Jul 14, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  4. Jun 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. May 14, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  6. May 14, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  7. May 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  8. Apr 15, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  9. Apr 15, 20263 EDGAR
  10. Apr 8, 2026SCHEDULE 13D/A EDGAR
  11. Apr 7, 2026SCHEDULE 13D EDGAR
  12. Apr 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  13. Mar 19, 20263 EDGAR
  14. Mar 18, 20263 EDGAR
  15. Mar 18, 20263 EDGAR
  16. Mar 18, 20263 EDGAR
  17. Mar 18, 20263 EDGAR
  18. Mar 18, 20263 EDGAR
  19. Mar 18, 20263 EDGAR
  20. Mar 18, 20263 EDGAR

The 175 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Moolec Science SA is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMoolec Science SA1
  • CIK0001937737
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company4
  • Incorporated inE94
  • Fiscal year endsJune 301
  • Industry code (SIC)2000 Food and Kindred Products1
  • SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance1
  • Business address89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands1
  • Phone352 26 49 65 651
  • Shares outstanding10,891,761 shares as of Jun 30, 20254
  • AuditorSebastian Azagra, Rosario, Argentina PCAOB ID 1349; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceAug 12, 20221
  • Filings175 in all: 6-K (64), 424B3 (22), CORRESP (14), EFFECT (11), UPLOAD (10), 3 (9), POS AM (8), 20-F (4)1
    All 28 form types

    F-4/A (4), 425 (3), SC 13D (3), DRSLTR (2), F-1 (2), F-1/A (2), F-4 (2), S-8 POS (2), SCHEDULE 13D/A (2), 20-F/A (1), 8-A12B (1), CERT (1), DEL AM (1), DRS (1), DRS/A (1), F-3 (1), NT 20-F (1), S-8 (1), SC 13D/A (1), SCHEDULE 13D (1)

  • Latest filingsAnnual report (20-F) Dec 29, 2025

Securities registered for trading

ClassSymbolExchange
Ordinary Shares, with nominal value of US$0.10 per shareMLECNasdaq Stock Market LLC
Warrants, exercisable for ordinary sharesMLECWNasdaq Stock Market LLC

From the cover page of the 20-F filed Dec 29, 2025 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19